These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8062205)

  • 1. A 32P-postlabelling assay for DNA adducts induced by cis-diamminedichloroplatinum(II).
    Försti A; Hemminki K
    Cancer Lett; 1994 Aug; 83(1-2):129-37. PubMed ID: 8062205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of TLC- and HPLC-32P-postlabelling assay for cisplatin-DNA adducts.
    Försti A; Staffas J; Hemminki K
    Carcinogenesis; 1994 Dec; 15(12):2829-34. PubMed ID: 8001242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new sensitive 32P-postlabeling assay based on the specific enzymatic conversion of bulky DNA lesions to radiolabeled dinucleotides and nucleoside 5'-monophosphates.
    Randerath K; Randerath E; Danna TF; van Golen L; Putman KL
    Carcinogenesis; 1989 Jul; 10(7):1231-9. PubMed ID: 2544310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 32P-postlabelling method for the detection of 7-alkylguanine adducts formed by the reaction of different 1,2-alkyl epoxides with DNA.
    Kumar R; Staffas J; Försti A; Hemminki K
    Carcinogenesis; 1995 Mar; 16(3):483-9. PubMed ID: 7697802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoranthene-DNA adducts: identification and quantification by an HPLC-32P-postlabeling method.
    Gorelick NJ; Wogan GN
    Carcinogenesis; 1989 Sep; 10(9):1567-77. PubMed ID: 2670301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 32P-adduct assay: comparative recoveries of structurally diverse DNA adducts in the various enhancement procedures.
    Gupta RC; Earley K
    Carcinogenesis; 1988 Sep; 9(9):1687-93. PubMed ID: 3409474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of UV-induced DNA photoproducts by 32P-postlabelling.
    Bykov VJ; Kumar R; Försti A; Hemminki K
    Carcinogenesis; 1995 Jan; 16(1):113-8. PubMed ID: 7834795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis.
    Randerath K; Liehr JG; Gladek A; Randerath E
    IARC Sci Publ; 1989; (96):189-205. PubMed ID: 2509347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and localization of cis-diamminedichloro-platinum(II) adducts on a purified oligonucleotide containing the codons 12 and 13 of H-ras proto-oncogene.
    Pillaire MJ; Villani G; Hoffmann JS; Mazard AM; Defais M
    Nucleic Acids Res; 1992 Dec; 20(24):6473-9. PubMed ID: 1480469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single d(GpG)/cis-diammineplatinum(II) adduct-induced inhibition of DNA polymerization.
    Suo Z; Lippard SJ; Johnson KA
    Biochemistry; 1999 Jan; 38(2):715-26. PubMed ID: 9888812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of reaction of cis-diamminedichloroplatinum(II) with DNA.
    Försti A; Leppälä S; Takala M; Laatikainen R; Hemminki K
    Pharmacol Toxicol; 1989 Jan; 64(1):120-5. PubMed ID: 2755902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some quantitative considerations about DNA adduct enrichment procedures for 32P-postlabelling.
    Vaca CE; Löfgren M; Hemminki K
    Carcinogenesis; 1992 Dec; 13(12):2463-6. PubMed ID: 1473258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel technique to assay adducts of DNA induced by anticancer agent cis-diamminedichloroplatinum(II).
    Sharma M; Jain R; Isac TV
    Bioconjug Chem; 1991; 2(6):403-6. PubMed ID: 1805936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion of DNA adducts of antitumour cis-diamminedichloroplatinum(II). Immunochemical analysis.
    Vrána O; Kiseleva VI; Poverenny AM; Brabec V
    Eur J Pharmacol; 1992 May; 226(1):5-13. PubMed ID: 1397055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The isolation and identification of cis-diamminedichloroplatinum (ii)-DNA adducts by anion-exchange HPLC and inductively coupled plasma mass-spectrometry.
    Morrison J; Bissett D; Stephens I; McKay K; Brown R; Graham M; Fichtingerschepman A; Kerr D
    Int J Oncol; 1993 Jan; 2(1):33-7. PubMed ID: 21573512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection by HPLC-32P-postlabelling of DNA adducts formed after exposure to epoxybutene and diepoxybutane.
    Leuratti C; Marafante E; Jones NJ; Waters R
    IARC Sci Publ; 1993; (124):277-82. PubMed ID: 8225496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved 32P-postlabelling assay for the quantification of the major platinum-DNA adducts.
    Welters MJ; Maliepaard M; Jacobs-Bergmans AJ; Baan RA; Schellens JH; Ma J; van der Vijgh WJ; Braakhuis BJ; Fichtinger-Schepman AM
    Carcinogenesis; 1997 Sep; 18(9):1767-74. PubMed ID: 9328174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring occupational exposure to carcinogens: detection by 32P-postlabelling of aromatic DNA adducts in white blood cells from iron foundry workers.
    Phillips DH; Hemminki K; Alhonen A; Hewer A; Grover PL
    Mutat Res; 1988 Mar; 204(3):531-41. PubMed ID: 3347220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of platinum-DNA adducts by 32P-postlabelling.
    Blommaert FA; Saris CP
    Nucleic Acids Res; 1995 Apr; 23(8):1300-6. PubMed ID: 7753620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement by 32P-postlabelling of 7-methylguanine levels in white blood cell DNA of healthy individuals and cancer patients treated with dacarbazine and procarbazine. Human data and method development for 7-alkylguanines.
    Mustonen R; Försti A; Hietanen P; Hemminki K
    Carcinogenesis; 1991 Aug; 12(8):1423-31. PubMed ID: 1860163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.